World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
55
Citations
9041
World Ranking
3828
National Ranking
150

Shuhji Seki publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Shuhji Seki sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 169 publications — 23rd percentile

23% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Shuhji Seki D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Shuhji Seki sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 55 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Shuhji Seki is affiliated with the National Defense Medical College in Japan and works primarily in the fields of immunology and microbiology as well as medicine. Their research has a focus on immune response, inflammation, and immune cell function, with an emphasis on molecular biology and clinical biochemistry aspects.

Their published work covers topics including immune response and inflammation, immune cell function and interaction, immunotherapy and immune responses, immune cells in cancer, T-cell and B-cell immunology, phagocytosis and immune regulation, and advanced glycation end products research.

Frequent publication venues for Shuhji Seki include:

  • American Journal of Physiology-Renal Physiology
  • Kidney & Blood Pressure Research
  • International Journal of Molecular Sciences
  • PLoS ONE
  • Scientific Reports

Notable recent papers from their research portfolio include:

  • Effects of a CCR2 antagonist on macrophages and Toll-like receptor 9 expression in a mouse model of diabetic nephropathy, 2021, American Journal of Physiology-Renal Physiology
  • Effects of L-Carnitine Treatment on Kidney Mitochondria and Macrophages in Mice with Diabetic Nephropathy, 2022, Kidney & Blood Pressure Research
  • Infections, Reactions of Natural Killer T Cells and Natural Killer Cells, and Kidney Injury, 2022, International Journal of Molecular Sciences
  • Contrasting functional responses of resident Kupffer cells and recruited liver macrophages to irradiation and liver X receptor stimulation, 2021, PLoS ONE
  • Liver X receptors regulate natural killer T cell population and antitumor activity in the liver of mice, 2021, Scientific Reports

Collaborative efforts have involved frequent co-authors such as:

  • Hiroyuki Nakashima
  • Masahiro Nakashima
  • Manabu Kinoshita
  • Takuya Ishikiriyama
  • Seigo Ito

Shuhji Seki's research extensively investigates mechanisms by which immune cells influence kidney injury and disease progression, especially in diabetic nephropathy models. The work also explores macrophage activity and natural killer T cell responses, which are relevant to tissue inflammation and immune regulation.

Overall, their contributions span multiple aspects of immunology, focusing on cellular interactions, molecular pathways, and immunological responses related to kidney function and pathology.

Best Publications

  • The liver as a crucial organ in the first line of host defense: the roles of Kupffer cells, natural killer (NK) cells and NK1.1 Ag+ T cells in T helper 1 immune responses.

    Shuhji Seki;Yoshiko Habu;Toshihiko Kawamura;Kazuyoshi Takeda

  • Characterization of two F4/80-positive Kupffer cell subsets by their function and phenotype in mice

    Manabu Kinoshita;Takefumi Uchida;Atsushi Sato;Masahiro Nakashima

  • Mechanisms of the Antimetastatic Effect in the Liver and of the Hepatocyte Injury Induced by α-Galactosylceramide in Mice

    Ryusuke Nakagawa;Ikuko Nagafune;Yoshiko Tazunoki;Hiromi Ehara

  • Decrease of CD56+T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma

    Nobuaki Kawarabayashi;Shuhji Seki;Kazuo Hatsuse;Takashi Ohkawa

  • Combined spinal and general anesthesia attenuates liver metastasis by preserving TH1/TH2 cytokine balance.

    Hiroki Wada;Shuhji Seki;Tetsuya Takahashi;Nobuaki Kawarabayashi

  • Details of an isolation method for hepatic lymphocytes in mice

    Hisami Watanabe;Kazuo Ohtsuka;Motohiko Kimura;Yoshinori Ikarashi

  • Estrogen administration activates extrathymic T cell differentiation in the liver.

    R Okuyama;T Abo;S Seki;T Ohteki

  • Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells

    Takashi Ohkawa;Shuhji Seki;Hiroshi Dobashi;Yuji Koike

  • Involvement of NK1+ T cells and their IFN-gamma production in the generalized Shwartzman reaction.

    Kouetsu Ogasawara;Kazuyoshi Takeda;Wataru Hashimoto;Masayuki Satoh

  • Mouse liver T cells: Their change with aging and in comparison with peripheral T cells

    A Tsukahara;S Seki;T Iiai;T Moroda

  • Characterization of cytokine and iNOS mRNA expression in situ during the course of experimental autoimmune myocarditis in rats.

    Yuji Okura;Tadashi Yamamoto;Shin Goto;Takayuki Inomata

  • Distinct development and functions of resident and recruited liver Kupffer cells/macrophages

    Masami Ikarashi;Hiroyuki Nakashima;Manabu Kinoshita;Atsushi Sato

  • Macrophage- and neutrophil- dominant arthritis in human IL-1α transgenic mice

    Yasuo Niki;Harumoto Yamada;Shuhji Seki;Toshiyuki Kikuchi

  • Neutrophil elastase, MIP-2, and TLR-4 expression during human and experimental sepsis.

    Hironori Tsujimoto;Satoshi Ono;Takashi Majima;Nobuaki Kawarabayashi

  • Induction of CD16+ CD56bright NK Cells with Antitumour Cytotoxicity not only from CD16− CD56bright NK Cells but also from CD16− CD56dim NK Cells

    E. Takahashi;N. Kuranaga;K. Satoh;Y. Habu

  • Recombinant Murine Interleukin-12 Facilitates Induction of Cardiac Myosin–Specific Type 1 Helper T Cells in Rats

    Yuji Okura;Kazuyoshi Takeda;Shigeru Honda;Haruo Hanawa

  • CD47 is an adverse prognostic factor and a therapeutic target in gastric cancer.

    Kazumichi Yoshida;Hironori Tsujimoto;Kouji Matsumura;Manabu Kinoshita

  • Superoxide produced by Kupffer cells is an essential effector in concanavalin A-induced hepatitis in mice.

    Hiroyuki Nakashima;Manabu Kinoshita;Masahiro Nakashima;Yoshiko Habu

  • Helicobacter pylori Augments Growth of Gastric Cancers via the Lipopolysaccharide-Toll-like Receptor 4 Pathway whereas Its Lipopolysaccharide Attenuates Antitumor Activities of Human Mononuclear Cells

    Kentaro Chochi;Takashi Ichikura;Manabu Kinoshita;Takashi Majima

  • Flagellin enhances NK cell proliferation and activation directly and through dendritic cell-NK cell interactions

    Hironori Tsujimoto;Takefumi Uchida;Philip A. Efron;Philip O. Scumpia

  • Activation of monocytes and endothelial cells depends on the severity of surgical stress.

    Suefumi Aosasa;Satoshi Ono;Hidetaka Mochizuki;Hironori Tsujimoto

Frequent Co-Authors

Hidetaka Mochizuki
Hidetaka Mochizuki National Defense Medical College
Toru Abo
Toru Abo Niigata University
Michael R. Hamblin
Michael R. Hamblin University of Johannesburg
Shinji Takeoka
Shinji Takeoka Waseda University
Makoto Makishima
Makoto Makishima Nihon University
Lyle L. Moldawer
Lyle L. Moldawer University of Florida
Kazuyoshi Takeda
Kazuyoshi Takeda Juntendo University
Makoto Handa
Makoto Handa Keio University
Hidenori Suzuki
Hidenori Suzuki Nippon Medical School
Shigeaki Nonoyama
Shigeaki Nonoyama National Defense Medical College

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related online degrees can open diverse career pathways in healthcare and research. Many professionals in this field choose to advance their education through specialized nursing programs or bridge courses designed to enhance clinical skills.

Nurses aiming for leadership roles may pursue a Doctor of Nursing Practice (DNP), with variations in earnings depending on location; for details, see average how much do dnp nurses make. This knowledge can guide career planning based on geographic preferences.

Transitioning between nursing specialties is common. For example, moving from family nurse practitioner roles to more critical care settings is facilitated by programs like the fnp to acute care np bridge program, which helps nurses adapt to acute care demands efficiently.

Accelerated pathways, such as the accelerated np program, allow qualified candidates to expedite their nurse practitioner credentials. These programs offer a fast track for those committed to advancing within healthcare.

For individuals without a nursing background but interested in entering the field quickly, online absn programs for non nurses provide accessible, flexible options to earn a Bachelor of Science in Nursing (BSN).

Overall, online education is a powerful resource for bridging knowledge gaps and enhancing credentials, making it a key component in the evolving landscape of immunology-related careers.

Best Scientists Citing Shuhji Seki

Trending Scientists

Recently Published Articles